GrantInsider
Atkins Susan E. — grant in BioXcel Therapeutics, Inc.
Director
17,000 shares · code A
View SEC EDGAR filing →Form 4 insider tape
Live SEC EDGAR Form 4 buys and sells for BTAI · 0 buys / 0 sells in this slice. Structured filings only — no AI rewrite. Informational — not investment advice.
Director
17,000 shares · code A
View SEC EDGAR filing →Officer (See Remarks)
35 shares · code M
View SEC EDGAR filing →Officer (Chief Financial Officer)
35 shares · code M
View SEC EDGAR filing →Officer (Chief Scientific Officer)
35 shares · code M
View SEC EDGAR filing →Officer (CEO and President), Director
219 shares · code M
View SEC EDGAR filing →